CClinicalTrials.gg
CompletedNCT05804617Updated Apr 7, 2023

Dome-type (Modified C-incision) Manual Morcellation During Laparoscopic Uterine Surgery

An interventional study of Dome-type (Modified C-incision) manual morcellation in Surgical Procedure, Unspecified, sponsored by National Taiwan University Hospital. Completed at 1 site in Taiwan. Open to female participants. Per ClinicalTrials.gov, last updated 2023-04-07.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled May 2020, registered Feb 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Sex
Female
01

Study summary

In-bag manual morcellation is a safe alternative procedure after FDA's discouragement of electronic power morcellator. The traditional wedging (V-type incision) or semicircular coring (C-type incision or ExCITE) method are the most common morcellation techniques. For beginners, it is somehow not that easy to get familiar with these methods. No teaching or learning experiences were reported. Therefore, we developed a dome-type (modified C-incision) technique to manually morcellate uteri leiomyoma or uterus at the time of laparoscopic surgery and report perioperative outcomes and the learning experiences of our residents for this technique from our two years of experience.

Read the detailed description

Background: In-bag manual morcellation is a safe alternative procedure after FDA's discouragement of electronic power morcellator. The traditional wedging (V-type incision) or semicircular coring (C-type incision or ExCITE) method are the most common morcellation techniques. For beginners, it is somehow not that easy to get familiar with these methods. No teaching or learning experiences were reported.

Objective: To describe using a dome-type (modified C-incision) technique to manually morcellate uteri leiomyoma or uterus at the time of laparoscopic surgery and report perioperative outcomes and the learning experiences of our residents for this technique from our two years of experience.

Study Design: Retrospective review of consecutive laparoscopic myomectomies or hysterectomies performed between May 2020 and September 2022 in which the specimen was manually morcellated using the dome-type technique by surgeon or trainees.

02

Conditions studied

  • Surgical Procedure, Unspecified
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women at any age undergoing laparoscopic surgeries with dome-type morcellation

Exclusion criteria

Exclusion Criteria:

  • Women with extremely huge specimen (>2000 gm)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
41 participants (actual)

Study arms

  • Placebo comparator
    Surgeon group

    Dome-type morcellation performed by one skillful surgeon

    Procedure: Dome-type (Modified C-incision) manual morcellation

  • Active comparator
    Trainee group

    Dome-type morcellation performed by trainees (residents) under supervision

    Procedure: Dome-type (Modified C-incision) manual morcellation

Interventions

  • ProcedureDome-type (Modified C-incision) manual morcellation

    Morcellation performed by surgeon or trainee

06

What researchers measure

Primary outcomes

  1. Morcellation speed

    Weight of specimen (gram) divided by morcellation time (minute)

    Time frame: During procedure

Secondary outcomes

  1. Age

    Age

    Time frame: Before procedure

  2. BMI (kg/m2)

    BMI

    Time frame: Before procedure

  3. Abdominal surgical history

    Any abdominal surgical history, e.g., Cesarean section, myomectomy, appendectomy...

    Time frame: Before procedure

  4. Stiffness

    Categorize to soft or hard

    Time frame: During procedure

  5. Umbilical wound size (cm)

    Umbilical wound size

    Time frame: During procedure

  6. Pathology

    Final pathologic result, e.g., leiomyoma, adenomyosis...

    Time frame: 1 week (after the pathologic report being released)

07

Study locations

1 site
  • National Taiwan University Hospital
    Taipei, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05804617
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Apr 7, 2023
Start date
May 20, 2020
Primary completion
Sep 1, 2022
Completion
Sep 1, 2022
Last update
Apr 7, 2023

Study contacts

Chi-Hau Chen, PhD
principal investigator · Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion